Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/CVS Health raises 2026 earnings and cash flow guidance after strong Q2 revenue and profit growth
CVS
$88.84
-$1.43 -1.58%

CVS Health raises 2026 earnings and cash flow guidance after strong Q2 revenue and profit growth

Company Fundamentals
05 Aug 2026
PRNewsWire
View Source
Bullish
CVS Health raises 2026 earnings and cash flow guidance after strong Q2 revenue and profit growth

CVS Health reported a 7.3% increase in total revenues to $106.1 billion for Q2 2026, with GAAP diluted EPS rising to $2.31 from $0.80 a year ago. Adjusted EPS also grew to $2.58, driven by improved margins in its Health Care Benefits segment. The company generated $10.6 billion in cash flow year-to-date and raised its full-year 2026 guidance for GAAP EPS to $6.84-$7.04 and adjusted EPS to $7.90-$8.10, reflecting strong performance across segments despite cautious outlook on costs and macro risks. CVS is expanding its healthcare services, including GLP-1 therapy support and AI-driven claims processing, aiming to enhance customer access and operational efficiency.

More News (CVS)

Aetna expands cancer treatment prior authorization bundles to all Medicaid members by 2027.

Aetna expands cancer treatment prior authorization bundles to all Medicaid members by 2027.

Aetna, a CVS Health company, is expanding its prior authorization bundles for all cancer types to eligible Medicaid members starting September 1, 2026, with plans to cover all its business lines by 2027. This initiative simplifies the approval proces...

Market News
Bullish
3 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App